otx2 has 63 expression phenotype(s)
Page: 1 2 3 4 5 6 7 ???pagination.result.next???
Images Sources Experiment + Assay Phenotypes Human Diseases
Fig. 3. B

Eroshkin FM et al. (2024)
Xla Wt + neurectoderm explant + stretch

NF14 (RT-PCR)
Expression Phenotype
decreased amount otx2.L expression in neuroectoderm
decreased amount cd82.L expression in neuroectoderm
decreased amount cebpa.L expression in neuroectoderm
decreased amount gsc.L expression in neuroectoderm
decreased amount six3.L expression in neuroectoderm
increased amount cdx4.L expression in neuroectoderm
increased amount tbxt.L expression in neuroectoderm
increased amount xmc.L expression in neuroectoderm
Fig. 5 H

Patel JH et al. (2022)
Xtr.Tg(pbin7:GFP) + hif1a MO

NF18 (in situ hybridization)
Anatomical Phenotype
abnormal neural plate morphology
abnormal Wnt signaling pathway
Expression Phenotype
mislocalised otx2 expression in forebrain
mislocalised en2 expression in hindbrain
Fig.7.C

Gur M et al. (2022)
Xla Wt + aldh1a2 CRISPR

NF12 (RT-PCR)
Expression Phenotype
decreased amount otx2.L expression in embryo
decreased amount aldh1a2.L expression in the embryo
decreased amount cer1.L expression in embryo
decreased amount chrd.1.L expression in the embryo
decreased amount hoxa1.L expression in embryo
decreased amount hoxb4.L expression in embryo
Fig.7.B

Gur M et al. (2022)
Xla Wt + aldh1a3 CRISPR

NF10.25 (RT-PCR)
Expression Phenotype
increased amount otx2.L expression in embryo
decreased amount admp.L expression in the embryo
decreased amount chrd.1.L expression in the embryo
decreased amount cyp26a1.L expression in the embryo
decreased amount frzb.L expression in the embryo
decreased amount hoxb4.L expression in embryo
Fig.3.A-G

Gur M et al. (2022)
Xla Wt + DEAB

NF10.25 (RT-PCR)
Expression Phenotype
decreased amount otx2.L expression in embryo
decreased amount admp.L expression in the embryo
decreased amount cer1.L expression in embryo
decreased amount chrd.1.L expression in the embryo
decreased amount cyp26a1.L expression in the embryo
decreased amount dkk1.L expression in embryo
decreased amount hoxb1.L expression in embryo
Fig.1.H

Gur M et al. (2022)
Xla Wt + DEAB

NF10.25 (RT-PCR)
Expression Phenotype
decreased amount otx2.L expression in embryo
decreased amount admp.L expression in the embryo
decreased amount cer1.L expression in embryo
decreased amount cyp26a1.L expression in the embryo
Fig.3.A-G

Gur M et al. (2022)
Xla Wt + Retinoic acid

NF10.25 (RT-PCR)
Expression Phenotype
decreased amount otx2.L expression in embryo
increased amount cyp26a1.L expression in the embryo
decreased amount admp.L expression in the embryo
decreased amount cer1.L expression in embryo
decreased amount chrd.1.L expression in the embryo
decreased amount dkk1.L expression in embryo
decreased amount muc2.L expression in cement gland
increased amount hoxb1.L expression in embryo
Fig.1.S1.D

Mukherjee S et al. (2020)
Xtr Wt + sox17a MO + sox17b.1/b.2 MO

NF10.5 (in situ hybridization)
Expression Phenotype
decreased amount otx2 expression in dorsal endomesoderm
decreased amount otx2 expression in dorsal involuting marginal zone
increased amount wnt8a expression in the animal cap
decreased amount admp expression in dorsal involuting marginal zone
decreased amount dhh expression in blastopore lip
decreased amount gata4 expression in endoderm
increased amount nodal1 expression in endoderm
increased amount nodal1 expression in marginal zone
increased amount nodal1 expression in ventral marginal zone
increased amount wnt8a expression in blastocoel floor
increased amount wnt8a expression in ectoderm
increased amount wnt8a expression in ventral marginal zone
Fig. 4 E

Shah AM et al. (2020)
Xla Wt + six1

NF28-32 (in situ hybridization)
Expression Phenotype
decreased amount otx2.L expression in otic vesicle
branchiootic syndrome
branchiootorenal syndrome
Fig. 4 E, Fig. 5 I

Shah AM et al. (2020)
Xla Wt + six1

NF28-32 (in situ hybridization)
Expression Phenotype
decreased amount otx2.L expression in otic vesicle
branchiootic syndrome
branchiootorenal syndrome